ScholarIQanswers from OpenAlex

Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study

PaperCitations, authors & open-access status

Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study have?

ScholarIQcitation count

Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study has 608 citations in the OpenAlex counts ScholarIQ stores.

When was Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study published?

ScholarIQyear

Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study has 2019 year in the ScholarIQ index.

What is the open-access status of Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study?

ScholarIQoa status

Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study has hybrid oa status in the ScholarIQ index.

What is the DOI of Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study?

ScholarIQdoi

The DOI for Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study is on the source record.

What is the PMID of Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study?

ScholarIQpmid

The PMID for Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study is on the source record.

What is the OpenAlex record for Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study?

ScholarIQopenalex

The OpenAlex for Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial